MIRA is advancing complementary non-opioid therapies for two of the largest pain markets MIAMI, FLORIDA / ACCESS Newswire / ...

Since the emergence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), understanding the mechanisms underlying ...

In conjunction with a rigorous preclinical validation platform in animal models, this system can aid the clinical translation of existing drugs with new cardiovascular indications tailored to ...

As a matter of fact, in NOD mice using a pancreatectomy/islet transplantation model, Kimura et al. have reported that the triggering of the diabetogenic autoimmune process needs to take place ...

WESTON, Fla. , March 05, 2025 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA, or “ZyVersa”), a clinical stage specialty biopharmaceutical company developing first-in-class drugs ...

The systemic immune-inflammation index showed a nonlinear positive correlation with all-cause and cardiovascular mortality in RA. A score of 529.7 or greater indicated high mortality risk.